Personal Perspective on Low-dosage Estrogen Therapy for Postmenopausal Women
- 1 January 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Menopause
- Vol. 6 (3) , 273-276
- https://doi.org/10.1097/00042192-199906030-00015
Abstract
As evidenced by results from recent clinical trials and epidemiological studies that have examined the physiological and clinical effects of low levels of estradiol, it is now time to replace the widely held belief that less than the standard dosage of estrogen is without benefit. Review of literature and personal experience. Studies indicate that low-dosage estrogen can relieve vasomotor symptoms, can prevent bone loss, and may reduce the risk of coronary heart disease. However, to achieve these health benefits, long-term estrogen use is required. Women who use low dosages of estrogens are less likely to have unacceptable side effects, such as irregular bleeding, heavy bleeding, or breast tenderness. Thus, long-term continuance of hormone replacement therapy (HRT) may be improved if lower dosages are given, particularly if the HRT regimen is tailored to the needs of the patient. Although standard-dosage estrogen remains the "gold standard" for HRT, having a low dosage as an alternative regimen can be useful. Attention of clinical researchers should focus on the effects of low-dosage estrogen on osteoporotic fractures and other health outcomes.Keywords
This publication has 13 references indexed in Scilit:
- Risk of Endometrial Cancer in Relation to Use of Low-Dose, Unopposed EstrogensObstetrics & Gynecology, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiolAmerican Journal of Obstetrics and Gynecology, 1997
- Patient Compliance of Women Taking Estrogen Replacement TherapyDrug Information Journal, 1997
- The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trialJAMA, 1996
- Efficacy and Local Tolerance of a Low-Dose, 7-Day Matrix Estradiol Transdermal System in the Treatment of Menopausal Vasomotor SymptomsObstetrics & Gynecology, 1996
- Continuation of Postmenopausal Hormone Replacement Therapy: Comparison of Cyclic Versus Continuous Combined SchedulesMenopause, 1996
- Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal agesClinical Endocrinology, 1996
- NAMS-Gallup Survey on Women??s Knowledge, Information Sources, and Attitudes to Menopause and Hormone Replacement TherapyMenopause, 1994
- Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with CalciumAnnals of Internal Medicine, 1987